company background image
301166 logo

Shanghai Universal BiotechLtd SZSE:301166 Stock Report

Last Price

CN¥26.17

Market Cap

CN¥2.3b

7D

0.2%

1Y

-39.7%

Updated

17 Jul, 2024

Data

Company Financials

Shanghai Universal Biotech Co.,Ltd.

SZSE:301166 Stock Report

Market Cap: CN¥2.3b

Shanghai Universal Biotech Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Universal BiotechLtd
Historical stock prices
Current Share PriceCN¥26.17
52 Week HighCN¥47.90
52 Week LowCN¥22.81
Beta1.45
11 Month Change-4.07%
3 Month Change-5.35%
1 Year Change-39.67%
33 Year Changen/a
5 Year Changen/a
Change since IPO-75.09%

Recent News & Updates

What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You

May 08
What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You

Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 03
Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Recent updates

What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You

May 08
What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You

Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 03
Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Shareholder Returns

301166CN HealthcareCN Market
7D0.2%2.4%1.0%
1Y-39.7%-36.1%-18.1%

Return vs Industry: 301166 underperformed the CN Healthcare industry which returned -36.1% over the past year.

Return vs Market: 301166 underperformed the CN Market which returned -18.1% over the past year.

Price Volatility

Is 301166's price volatile compared to industry and market?
301166 volatility
301166 Average Weekly Movement6.8%
Healthcare Industry Average Movement5.2%
Market Average Movement6.2%
10% most volatile stocks in CN Market9.4%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 301166's share price has been volatile over the past 3 months.

Volatility Over Time: 301166's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004731Zhaowu Lengwww.univ-bio.com

Shanghai Universal Biotech Co.,Ltd. distributes and supplies antibodies and protein products. The company offers antibodies, recombinant proteins, detection kits, antigens, and other products, as well as biochemical reagents, molecular biology reagents, and cell biology reagents.

Shanghai Universal Biotech Co.,Ltd. Fundamentals Summary

How do Shanghai Universal BiotechLtd's earnings and revenue compare to its market cap?
301166 fundamental statistics
Market capCN¥2.27b
Earnings (TTM)CN¥27.60m
Revenue (TTM)CN¥1.22b

82.2x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301166 income statement (TTM)
RevenueCN¥1.22b
Cost of RevenueCN¥1.00b
Gross ProfitCN¥222.11m
Other ExpensesCN¥194.51m
EarningsCN¥27.60m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 30, 2024

Earnings per share (EPS)0.32
Gross Margin18.16%
Net Profit Margin2.26%
Debt/Equity Ratio0%

How did 301166 perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

145%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.